Skip to main content
. 2013 Nov 27;13:561. doi: 10.1186/1471-2334-13-561

Table 2.

Microbiology grouped by HCAP, HAP, and VAPa

Microbiology
HCAP
HAP
VAP
(n = 199)
(n = 379)
(n = 606)
  n (%) n (%) n (%)
Gram-positive pathogens
117 (58.8)
226 (59.6)
441 (72.8)
 MRSA
82 (41.2)
125 (33.0)
259 (42.7)
 MSSA
12 (6.0)
51 (13.5)
107 (17.7)
Pneumococcus
4 (2.0)
10 (2.6)
15 (2.5)
 Other Streptococcus spp.
7 (3.5)
15 (4.0)
18 (3.0)
Gram-negative pathogens
53 (26.6)
113 (29.8)
222 (36.6)
Pseudomonas aeruginosa
22 (11.1)
28 (7.4)
57 (9.4)
Acinetobacter spp.
8 (4.0)
16 (4.2)
44 (7.3)
Haemophilus spp.
6 (3.0)
5 (1.3)
23 (3.8)
Moraxella catarrhalis
4 (2.0)
1 (0.3)
2 (0.3)
Klebsiella spp.
5 (2.5)
32 (8.4)
41 (6.8)
Escherichia coli
10 (5.0)
19 (5.0)
17 (2.8)
Enterobacter spp.
3 (1.5)
15 (4.0)
31 (5.1)
Proteus mirabilis
1 (0.5)
8 (2.1)
13 (2.1)
Stenotrophomonas maltophilia
0 (0)
2 (0.5)
13 (2.1)
Polymicrobial
111 (55.8)
191 (50.4)
387 (63.9)
Culture negative
50 (25.1)
101 (26.6)
79 (13.0)
Bacteremia 28 (14.1) 49 (12.9) 103 (17.0)

HAP, Hospital-acquired pneumonia; HCAP, Healthcare-associated pneumonia; MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, Methicillin-susceptible S. aureus; VAP, Ventilator-associated pneumonia.

aMost commonly isolated pathogens reported (at least 2% in HCAP, HAP, or VAP).